On the Horizon*

TARGET DATE

BRAND NAME

GENERIC NAME

COMMON USE

2017 U.S.
BRAND SALES

1H2019 ADVAIR DISKUS Fluticasone-salmeterol Asthma, COPD $2,075M
1H2019 AMITIZA (24 mcg capsule) Lubiprostone Constipation $351M
1H2019 RANEXA Ranolazine Chronic angina $889M
1H2019 BYSTOLIC Nebivolol Hydrochloride Hypertension $967M
1H2019 BROVANA Arformoterol Tartrate COPD $495M
2H2019 AFINITOR (10 mg) Everolimus Breast, pancreatic, kidney cancers $375M
2H2019 FASLODEX Fulvestrant Breast cancer $498M
2H2019 PROVENTIL-HFA Albuterol Asthma $17M
2H2019 REMODULIN Treprostinil Pulmonary arterial hypertension $671M
2020 LYRICA (capsules) Pregabalin Neuralgia, neuropathies, fibromyalgia, seizures $4,907M
2020 TRAVATAN Z Travoprost Glaucoma $544M
2020 ABSORICA Isotretinoin Acne $461M
2020 VIIBRYD Vilazodone Hydrochloride Depression $367M
2020 ULORIC Febuxostat Gout $545M

*Source for upcoming first generic launches table: IPD Analytics, http://www.ipdanalytics.com; accessed February 1, 2019

Legal Disclaimer | Privacy | Product Disclosures | Cigna Company Names

Health benefit plans vary, but in general to be eligible for coverage a drug must be approved by the Food and Drug Administration (FDA), prescribed by a health care professional, purchased from a licensed pharmacy and medically necessary. Some plans require use an in-network pharmacy for prescriptions to be covered. Coverage is subject to any plan deductible, copayment and/or coinsurance requirements. Product availability may vary by location and plan type and is subject to change. All group health insurance policies and health benefit plans contain exclusions and limitations. For costs and complete details of prescription drug coverage, contact a Cigna representative.

All Cigna products and services are provided exclusively by or through operating subsidiaries of Cigna Corporation, including Cigna Health and Life Insurance Company, (CHLIC), Cigna Behavioral Health, Inc., Cigna Health Management, Inc., Accredo Health Group, Inc., Express Scripts, Inc., ESI Mail Pharmacy Service, Inc., Express Scripts Pharmacy, Inc., Tel-Drug, Inc., Tel-Drug of Pennsylvania, L.L.C., Lynnfield Drug, Inc., and HMO or service company subsidiaries of Cigna Health Corporation. Policy forms: OK - HP-APP-1 et al., OR - HP-POL38 02-13, TN - HP-POL43/HC-CER1V1 et al. (CHLIC). The Cigna name, logo, and other Cigna marks are trademarks of Cigna Intellectual Property, Inc. "Express Scripts" is a trademark of Express Scripts Strategic Development, Inc. This newsletter is not intended for residents of New Mexico.

© 2021 Cigna. All rights reserved